[1]魏俊杰.深圳地区10~40周岁健康人群血清抗A(B)IgG抗体效价参考区间的建立与应用分析[J].现代检验医学杂志,2021,36(04):136-138.[doi:10.3969/j.issn.1671-7414.2021.04.029]
 WEI Jun-jie.Establishment and Application Analysis of Serum Anti-A(B) IgG AntibodyTiter Reference Interval of Healthy People Aged 10~40 in Shenzhen Area[J].Journal of Modern Laboratory Medicine,2021,36(04):136-138.[doi:10.3969/j.issn.1671-7414.2021.04.029]
点击复制

深圳地区10~40周岁健康人群血清抗A(B)IgG抗体效价参考区间的建立与应用分析()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年04期
页码:
136-138
栏目:
研究简报·实验技术
出版日期:
2021-07-31

文章信息/Info

Title:
Establishment and Application Analysis of Serum Anti-A(B) IgG AntibodyTiter Reference Interval of Healthy People Aged 10~40 in Shenzhen Area
文章编号:
1671-7414(2021)04-136-03
作者:
魏俊杰
(南方医科大学深圳医院输血科,广东深圳 518000)
Author(s):
WEI Jun-jie
(Department of Transfusion Medicine, Shenzhen Hospital of Southern Medical University, , Guangdong Shenzhen 518000, China)
关键词:
健康人群血清IgG 抗A(B)效价效价区间
分类号:
R457.12
DOI:
10.3969/j.issn.1671-7414.2021.04.029
文献标志码:
A
摘要:
目的 建立深圳地区10 ~ 40 周岁健康人群血清IgG 抗A(B)抗体效价参考区间。方法 选取深圳地区年龄为10 ~ 40 周岁南方医科大学深圳医院健康未孕体检者共1 500 例,按性别分成男女2 组, 每组再按照年龄分成3 个亚组,检测血清IgG 抗A(B)抗体效价。结果 深圳地区10 ~ 40 周岁健康人群血清IgG 抗A(B)抗体效价参考区间范围为1:8 ~ 1:64。IgG 抗A 抗体效价以及IgG 抗B 抗体效价,在不同性别中分布差异无统计学意义(χ2=0.492, 1.011,均P>0.05)。IgG 抗A 抗体效价在3 个年龄亚组中分布差异无统计学意义(χ2=5.464, P>0.05),但IgG 抗B 抗体效价在3 个年龄亚组中分布差异有统计学意义(χ2=10.083, P<0.05)。结论 深圳地区10 ~ 40 岁健康人群血清IgG 抗A(B)抗体效价区间范围为1:8 ~ 1:64,可为预测新生儿溶血病(HDN)的发病预警提供基础数据和科学依据。

参考文献/References:

[1] 雷慧芬,樊凤艳,肖军,等.国内医疗机构胎儿新生儿溶血病免疫血液学检测情况分析[J].临床输血与检验,2021,23(1):33-38.LEI Huifen,FAN Fengyan,XIAO Jun, et al.Immunohematological tests of hemolytic disease of thefetus and newborn: A questionnaire survey in domesticmedical facilities[J].Journal of Clinical Transfusion andLaboratory Medicine,2021,23(1):33-38.
[2] 陈卓瑶,邓秋连,黄映红,等.溶血三项检测血清总胆红素及IgG 抗体效价与新生儿ABO 溶血病的关系探讨[J]. 新疆医科大学学报, 2020, 43(8): 1069-1072.CHEN Zhuoyao, DENG Qiulian, HUANG Yinghong, etal. Analysis of the relationship between three hemolysistests,serum total bilirubin and IgG antibody titer andABO hemolytic disease of newborn [J]. Journal ofXinjiang Medical University, 2020, 43(8): 1069-1072.
[3] 陈蕾, 罗明, 柳月霞. 孕妇血清IgG 抗A 抗B 水平检测用于早期诊断ABO-HDN 的临床价值分析[J].医学理论与实践, 2020, 33(24): 4062-4064.CHEN Lei, LUO Ming, LIU Yuexia. Clinical valueof detection of serum IgG anti-A and anti-B levels inpregnant women for early diagnosis of ABO-HDN[J]. the Journal of Medical Theory and Practice, 2020,33(24): 4062-4064 .
[4] 王怡洁,火艳华.孕妇血型抗体与新生儿溶血病的血清检查研究[J]. 大医生, 2020, 5(2): 100-102.WANG Yijie, HUO Yanhua. Study on serum examinationof maternal blood group antibody and hemolyticdisease of newborn [J]. Doctor, 2020, 5(2): 100-102.
[5] 黄海燕,江祥勇,雷云.微柱凝胶技术在ABO 新生儿溶血病产前母体效价测定中的应用评估[J]. 黑龙江中医药,2020, 49(3): 119-120.HUANG Haiyan, JIANG Xiangyong, LEI Yun.Application evaluation of microcolumn geltechnology in the determination of prenatal maternaltiter of ABO neonatal hemolytic disease[J].Heilongjiang Journal of Traditional ChineseMedicine, 2020, 49(3): 119-120.
[6] 程峰,鹿艳,候莉莉.孕妇IgG- 抗A(B) 抗体效价监测在预防和诊断新生儿溶血病中的应用分析[J].中国医药指南, 2018, 16(1) :168-169.CHENG Feng, LU Yan, HOU Lili. Application analysisof pregnant women IgG-anti-A(B) antibody titermonitoring in the prevention and diagnosis of neonatalhemolytic disease[J]. Guide of China Medicine, 2018,16(1) :168-169.
[7] 蒋璐茜,杜垚强,谢一唯,等.不同孕期ABO 血型IgG 抗体效价预测新生儿溶血病发生的效能比较[J]. 浙江医学,2020,42(22):2417-2420.JIANG Luqian, DU Yaoqiang, XIE Yiwei, et al. Titersof anti-A or anti-B IgG in predicting the occurrenceof hemolytic disease of fetus or newborn [J]. ZhejiangMedical Journal,2020,42(22):2417-2420.
[8] 盛晓星.微柱凝胶法检测孕妇血清IgG 抗体效价参考值的临床研究[J]. 实用妇科内分泌电子杂志,2019,6(21):78-79.SHENG Xiaoxing. A clinical study on the referencevalue of IgG antibody titer in pregnant women bythe microcolumn gel method[J]. Journal of PracticalGynecologic Endocrinology, 2019, 6(21): 78-79.

相似文献/References:

[1]刘运双,张 彬,张亚梅,等.健康人群和慢性肾病患者基于血清CysC水平估算肾小球滤过率公式的适用性评价[J].现代检验医学杂志,2018,33(03):54.[doi:10.3969/j.issn.1671-7414.2018.03.015]
 LIU Yun-shuang,ZHANG Bin,ZHANG Ya-mei,et al.Evaluating of the Applicability of Estimated Glomerular Filtration Rate Formula Based on Cystatin C in Healthy Population and Chronic Kidney Disease Patients[J].Journal of Modern Laboratory Medicine,2018,33(04):54.[doi:10.3969/j.issn.1671-7414.2018.03.015]
[2]孟凡娜,孙 丽.重庆地区健康体检人群中幽门螺旋杆菌感染现状研究分析[J].现代检验医学杂志,2018,33(05):121.[doi:10.3969/j.issn.1671-7414.2018.05.033]
 MENG Fan-na,SUN Li.Analysis of Helicobacter Pylori Infection in Healthy Population in Chongqing Area[J].Journal of Modern Laboratory Medicine,2018,33(04):121.[doi:10.3969/j.issn.1671-7414.2018.05.033]

备注/Memo

备注/Memo:
基金项目:深圳市宝安区科技创新局项目(项目编号:2020JD451);深圳市科技创新委员会项目(项目编号:JCYJ20190814110401673)。
作者简介:魏俊杰(1982-),男,医学学士,主管技师,主要研究方向:临床输血技术,E-mail:55151220@qq.com。
更新日期/Last Update: 1900-01-01